Molecular cytogenetics of childhood acute myelogenous leukaemias

European Journal of Haematology

Volumn 59, Issue 1, 1997, Pages 1-13

  Leblanc, Thierry ^a   Berger, Roland ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Childhood acute myeloblastic leukaemia; Children; Chromosome abnormalities

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME ABERRATION; HUMAN; INFANT; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0030795080     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb00953.x     Document Type: Review

References (105)

1. MERTENS F, JOHANSSON B, MITELMAN F. Age- and gender-related heterogeneity of cancer chromosome aberrations. Cancer Genet Cytogenet 1993: 70: 6-11.
2. BENNET JM, CATOVSKY D, DANIEL MT, et al. Proposals for the classification of the acute leukaemias. Br J Haematol 1976: 33: 451-460.
3. BENNET JM, CATOVSKY D, DANIEL MT, et al. Criteria for the diagnosis of acute leukemia of megacaryocyte lineage (M7). Ann Intern Med 1985: 103: 460-462.
4. BENNET JM, CATOVSKY D, DANIEL MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985: 103: 626-629.
5. BENNET JM, CATOVSKY D, DANIEL MT, et al. Proposals for the recognition of minimally differentiated acute myeloid leukaemia. Br J Haematol 1991: 78: 325-329.
6. CUNEO A, FERRANT A, MICHAUX JL, et al. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings. Blood 1995: 85: 3688-3694.
7. LEVERGER G, BERNHEIM A, DANIEL, MT, FLANDRIN G, SCHAISON G, BERGER R. Cytogenetic study of 130 childhood acute nonlymphocytic leukemias. Med Pediatr Oncol 1988: 16: 227-232.
8. RAIMONDI SC, KALWINSKY DK, HAYAASHI Y, et al. Cytogenetics of childhood acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1989: 40: 13-27.
9. MARTINEZ-CLIMENT JA, LANE NJ, RUBIN CM, et al. Clinical and prognosis significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995: 9: 95-101.
10. LEBLANC T, AUVRIGNON A, MICHEL G, et al. Prognostic value of cytogenetics in 250 children treated in the LAME 89/91 protocol. Blood 1996: 88 [Suppl 1]: 634a (Abstract 2524).
11. BERGER R, FLANDRIN G, BERNHEIM A, et al. Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. Cancer Genet Cytogenet 1987: 29: 9-21.
12. HURWITZ CA, RAIMONDI SC, HEAD D, et al. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 1992: 80: 3182-3188.
13. GALLEGO M, CARROLL AJ, GAD GS, et al. Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhood. Cancer Genet Cytogenet 1994: 75: 139-144.
14. SCHOCH C, HAASE D, HAFERLACH T, et al. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor. Leukemia 1996: 10: 1288-1295.
15. GROUPE FRANÇAIS DE CYTOGENETIOUE. Acute myelogenous leukemia with an 8;21 translocation. A report on 148 cases from the Groupe Français de Cytogenetique Hematologique. Cancer Genet Cytogenet 1990: 44: 169-179.
16. MIYOSHI H, SHIMIZU K, KOZU T, MASEKI N, KANEKO Y, OHKI M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene. AML1. Proc Natl Acad Sci USA 1991: 88: 10431-10434.
17. NUCIFORA G, ROWLEY JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 1995: 86: 1-14.
18. OKUDA T, VAN DEURSEN J, HIEBERT SW, GROSVELD G, DOWNING JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996: 84: 321-330.
19. KOZU T, MIYOSHI H, SHIMIZU K, et al. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 1993: 82: 1270-1276.
20. TOBAL K, YIN JAL. Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for ML1-MTG8 transcripts in AML-M2 with t(8;21). Blood 1996: 88: 3704-3719.
21. JOHANSSON B, FIORETOS T, GARWICZ S, HEIM S, MITELMAN F. t(3;21)(q26;q22) with AML1 rearrangement in a de novo acute monoblastic leukaemia. Br J Haematol 1996: 92: 429-431.
22. LEMONS RS, KELLER S, GIETZEN D, et al. Acute promyelocytic leukemia. J Pediatr Hematol Oncol 1995: 17: 198-210.
23. DE THE H, CHOMIENNE C, LANOTTE M, DEGOS L, DEJEAN A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 1990: 347: 558-561.
24. BORROW J, GODDARD AD, SHEER D, SALOMON E. Molecular analysis of acute promyelocytic cluster region on chromosome 17. Science 1990: 249: 1577-1580.
25. GRIGNANI F, FAGIOLI M, ALCALAY M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994: 83: 10-25.
26. KANE JR, HEAD DR, BALAZS L, et al. Molecular analysis of the PML/RARa chimeric gene in pediatric acute promyelocytic leukemia. Leukemia 1996: 10: 1296-1302.
27. BERGER R, BERNHEIM A, FLANDRIN G. Absence d'anomalies chromosomiques et leucémies aiguës: relation avec les cellules médulaires normales. CR Acad Sci (Série D). Paris, 1980: 290: 1557-1559.
28. CHEN Z, BRAND NJ, CHEN A, et al. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 1993: 12: 1161-1167.
29. BRUNEL V, SAINTY D, CARBUCCIA N, et al. Unbalanced translocation t(5;17) in an atypical acute promyelocytic leukemia. Genes Chromosom Cancer 1995: 14: 307-312.
30. DEGOS L, DOMBRET H, CHOMIENNE C, et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995: 85: 2643-2653.
31. HAFERLACH T, WINKEMANN M, LOFFLER H, et al. The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization. Blood 1996: 87: 2459-2463.
32. ADRIAANSEN HJ, BOEKHORST PA, HAGEMEIJER AM, VAN DER SCHOOT CE, DELWEL HR, VAN DONGEN JJ. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993: 81: 3043-3051.
33. DAUWERSE JG, JUMELET EA, WESSELS JW, et al. Extensive cross-homology between the long and the short arm of chromosome 16 may explain leukemic inversions and translocations. Blood 1992: 79: 1299-1304.
34. CAMPBELL LJ, CHALLIS J, FOK T, GASSON OM. Chromosome 16 abnormalities associated with myeloid malignancies. Genes Chromosom Cancer 1991: 3: 55-61.
35. LIU P, TARLE SA, HAJRA A, et al. Fusion between transcription factor CBF beta/PEPB2 beta and myosin heavy chain in acute myeloid leukemia. Science 1993: 261: 1041-1044.
36. LIU PP, HAJRA A, WIJMENGA C, COLLINS FS. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995: 85: 2289-2302.
37. HERBERT J, CAYUELA JM, DANIEL M, BERGER R, SIGAUX F. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification. Blood 1994: 84: 2291-2296.
38. CIMINO G, RAPANOTTI MC, ELIA L, et al. ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young age. Cancer Res 1995: 55: 1625-1628.
39. BERGER R, BERNHEIM A, DANIEL MT, FLANDRIN G. Cytogenetic studies on acute monocytic leukemia. Leuk Res 1980: 4: 119-127.
40. YOUNG BD. Cytogenetic and molecular analysis of chromosome 11q23 abnormalities in leukemia. Baillère's Clinical Haematology 1992: 5: 881-895.
41. RUBNITZ JE, BEHM FG, DOWNING JR. 11q23 rearrangements in acute leukemia. Leukemia 1996: 10: 74-82.
42. ZIEMIN-VAN DER POEL S, MCCABE NR, GILL HJ, et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 1991: 88: 10735-10739.
43. CIMINO G, MOIR DT, CANAANI O, et al. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res 1991: 51: 6712-6714.
44. DJABALI M, SELLERI L, PARRY P, BOWER M, YOUNG BD, EVANS GA. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat Genet 1992: 2: 113-118.
45. GU Y, NAKAMURA T, ALDER H, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the all-1 gene, related to Drosophilia trithorax, to the AF4 gene. Cell 1992: 71: 701-708.
46. TKACHUK DC, KOHLER S, CLEARY ML. Involvement of a homolog of Drosophilia-trithorax by 11q23 translocations in acute leukemias. Cell 1992: 71: 691-700.
47. SMITH FO, RAUCH C, WILLIAMS DE, et al. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23. Blood 1996: 87: 1123-1133.
48. BEVERLOO HB, LE CONIAT M, WIJSMAN J, et al. Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization. Cancer Res 1995: 55: 4220-4224.
49. CHERIF D, ROMANA S, DER-SARKISSIAN H, JONES C, BERGER R. Chromosome painting in acute monocytic leukemia. Genes Chromosom Cancer 1993: 6: 107-112.
50. ROWLEY JD, DIAZ MO, ESPINOSA III R, et al. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 1990: 87: 9358-9362.
51. CHERIF D, BERNARD O, PAULIEN S, JAMES MR, LE PASLIER D, BERGER R. Hunting 11q23 deletions with fluorescence in situ hybridization (FISH). Leukemia 1994: 8: 578-586.
52. RASIO D, SCHICHMAN SA, NEGRINI M, CANAANI E, CROCE CM. Complete exon structure of the ALL1 gene. Cancer Res 1996: 56: 1766-1769.
53. NILSON I, LÖCHNER K, SIEGLER G, et al. Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. Br J Haematol 1996: 93: 966-972.
54. BERNARD O, BERGER R. Molecular basis of 11q23 rearrangements in hematopietic malignant proliferations. Genes Chromosom Cancer 1995: 13: 75-85.
55. CIMINO G, RAPANOTTI MC, ELIA L, et al. ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young ages. Cancer Res 1995: 55: 1625-1628.
56. SORENSEN PHB, CHEN C-S, SMITH, et al. Molecular rearrangement of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest 1994: 93: 429-437.
57. REPP R, BORKHARDT A, HAUPT E, et al. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. Leukemia 1995: 9: 210-215.
58. BORKHARDT A, REPP R, HAAS OA, et al. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene 1997: 14: 195-202.
59. SCHICHMAN SA, CANAANI E, CROCE CM. Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia. JAMA 1995: 273: 571-576.
60. BERNARD O, ROMANA SP, SCHICHMAN SA, MAUCHAUFFE M, JONVEAUX P, BERGER R. Partial duplication of HRX in acute leukemia with trisomy 11. Leukemia 1995: 9: 1487-1490.
61. CORRAL J, LAVENIR I, IMPEY H, et al. An MLL-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 1996: 85: 853-861.
62. KALWINSKY DK, RAIMONDI SC, SCHELL MJ, et al. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 1990: 8: 75-83.
63. HEIM S, AVANZI G-C, BILLSTRÖM R, et al. A new specific chromosomal rearrangement, t(8;16)(p11;p13), in acute monocytic leukaemia. Br J Haematol 1987: 66: 323-326.
64. STARK B, RESNITZKY P, JEISON M, et al. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8;16)(p11;p13), in a patient with the variant t(8;19)(p11;q13). Case report and review of the literature. Leuk Res 1995: 19: 367-379.
65. BORROW J, STANTON JR VP, ANDRESEN JM, et al. The translocation (8;16)(p11;p13) of acute myeloid leukaemia fuses a privative acetyltransferase to the CREB-binding protein. Nat Genet 1996: 14: 33-41.
66. BERNHEIM A, BERGER R, DANIEL M-T, VALENSI F, FLANDRIN G. Malignant and reactive erythroblasts in erythroleukemia (M6). Cancer Genet Cytogenet 1983: 9: 1-10.
67. STAMBERG J. Chromosome abnormalities in erythroleukemia. Cancer 1987: 60: 2649-2653.
68. MALKIN D, FREEDMAN MH. Childhood erythroleukemia: review of clinical and biological features. Am J Pediat Hematol/Oncol 1989: 11: 348-359.
69. MITELMAN F, JOHANSSON B, MERTENS F. Catalog of chromosome aberations in cancer (Fifth edition). Wiley-Liss, New York, 1994.
70. LU G, ALTMAN AJ, BENN PA. Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several? Cancer Genet Cytogenet 1993: 67: 81-89.
71. JANI SAIT SN, BRECHER ML, GREEN DM, SANDBERG AA. Translocation t(1;22) in congenital acute megakaryoblastic leukemia. Cancer Genet Cytogenet 1988: 34: 277-280.
72. STORK L, WILSON H, MIERAU G, et al. Heterogeneity of acute "undifferentiated" leukemia of childhood: ultrastructural, immunophenotypic, and karyotypic analysis. Am J Pediatr Hematol Oncol 1990: 12: 34-44.
73. CARROLL A, CIVIN C, SCHNEIDER N, et al. The t(1;22)(p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study. Blood 1991: 78: 748-752.
74. BARUCHEL A, DANIEL MT, SCHAISON G, BERGER R. Nonrandom t(1;22)(p12-p13;q13) in acute megakaryocytic malignant proliferation. Cancer Genet Cytogenet 1991: 54: 239-243.
75. LION T, HAAS OA, HARBOTT J, et al. The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children. Blood 1992: 79: 3325-3330.
76. CHAN WC, CARROLL A, ALDAVARO CS. Acute megakaryoblastic leukemia in infants with t(1;22)(p13;q13) abnormality. Am J Clin Pathol 1992: 98: 214-221.
77. WASHIO S, IDO M, AZUMA E, et al. Acute megakaryoblastic leukemia with translocation t(1;22)(p13;q13) in a 10-week-old infant. Am J Hematol 1991: 39: 56-60.
78. SCNAMI S, FUSE A, SIMIZU B, et al. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome. Blood 1987: 70: 368-371.
79. BARANGER L, BARUCHEL A, LEVERGER G, SCHAISON G, BERGER R. Monosomy-7 in childhood hematopoietic disorders. Leukemia 1990: 4: 345-349.
80. LUNA-FINEMAN S, SHANNON KM, LANGE BJ. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood 1995: 85: 1985-1999.
81. LE BEAU MM, ESPINOZA R, DAVIS EM, EISENBART JD, LARSON RA, GREEN ED. Cytogenetic and molecular definition of a region of chromosome 7 commonly detected in malignant myeloid diseases. Blood 1996: 88: 1930-1935.
82. JOHNSON EJ, SCHERER SW, OSBORNE L, et al. Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood 1996: 87: 3579-3686.
83. KALRA R, DALE D, FREEDMAN M, et al. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 1995: 86: 4579-4586.
84. SOEKARMAN D, VON LINDERN M, DAENEN S, et al. The translocation (6;9)(p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorders with specific clinical features. Blood 1992: 79: 2990-2997.
85. LILLINGTON DM, MACCALLUM PK, LISTER A, GIBBONS B. Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and review of the literature. Leukemia 1993: 7: 527-531.
86. FORNEROD M, BOER J, VAN BAAL S, et al. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene 1995: 1739-1748.
87. FORNEROD M, BOER J, VAN BAAL S, MORREAU H, GROSVELD G. Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. Oncogene 1996: 13: 1801-1808.
88. PUI C-H, KANE JR, CRIST WM. Biology and treatment of infant leukemias. Leukemia 1995: 9: 762-769.
89. FORD AM, RIDGE SA, CABRERA ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 1993: 363: 358-360.
90. CIMINO G, RAPANOTTI MC, RIVOLTA A, et al. Prognostic relevance of ALL-1 gene rearrangements in infant acute leukemias. Leukemia 1995: 9: 391-395.
91. TAKI T, IDA K, BESSHO F, et al. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia. Leukemia 1996: 10: 1303-1307.
92. PUT C-H, RAIMONDI SC, MURPHY SB, et al. An analysis of leukemic cell chromosomal features in infants. Blood 1987: 69: 1289-1293.
93. ISHII E, OKAMURA J, TSUCHIDA M, et al. Infant leukemia in Japan: clinical and biological analysis of 48 cases. Med Pediatr Oncol 1991: 19: 28-32.
94. SANSONE R, NEGRI D. Cytogenetic features of neonatal leukemias. Cancer Genet Cytogenet 1992: 63: 56-61.
95. ZIPURSKY A, POON A, DOYLE J. Leukemia in Down syndrome: a review. Pediat Hematol Oncol 1992: 9: 139-149.
96. AVET-LOISEAU H, MECHINAUD F, HAROUSSEAU J-L. Clonal hematologic disorders in Down syndrome. J Pediatr Hematol Oncol 1995: 17: 19-24.
97. RAVINDRANATH Y, ABELLA E, KRISCHER JP, et al. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience of Pediatric Oncology Group AML Study 8498. Blood 1992: 2210-2214.
98. LIE S, JONMUNDSSON G, MELLANDER L, et al. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants and children with Down's syndrome. Br J Haematol 1996: 94: 82-88.
99. HOMANS AC, VERISSIMO AM, VLACHA V. Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediat Hematol/Oncol 1993: 15: 392-399.
100. RUBIN CM, ARTHUR DC, WOODS WG, et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood 1991: 78: 2982-2988.
101. SCHELLONG G, RIEPENHAUSEN M, CREUTZIG U, et al. Incidence of secondary leukemias after therapy of childhood Hodgkin's disease without nitrogen-mustard. Results of the German-Austrian study group. In: BÜCHNER T, HIDDEMANN W, WÖRMANN B, SCHELLONG G, RITTER J, CREUTZIG U, eds. Haematology and blood transfusion No 38. Acute Leukemias VI. Prognostic factors and treatment strategies. Springer-Verlag, Berlin, 1997: 898-904.
102. PEDERSEN-BJERGAARD J, DAUGAARD G, HANSEN SW, PHILIP P, LARSEN SO, RORTH M. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin and bleomycin for germ-cell tumours. Lancet 1991: 338: 359-363.
103. PUI C-H, RIBEIRO RC, HANCOCK ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991: 325: 1682-1687.
104. FELIX CA, HOSLER MR, WINICK NJ, MASTERSON M, WILSON AE, LANGE BJ. ALL-1 gene rearrangements in DNA toposisomerase II inhibitor-related leukemia in children. Blood 1995: 85: 3250-3256.
105. PUI C-H, RELLING MV, RIVERA GK, et al. Epipodophyllotoxin-related acute myeloid: a study of 35 cases. Leukemia 1995: 1990-1996.